United States Treprostinil Market Report 2016

November 2016 | 96 pages | ID: U8C2FD0B61BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Treprostinil

Revenue, means the sales value of Treprostinil

This report studies sales (consumption) of Treprostinil in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• GlaxoSmithKline Plc (UK)
• Eli Lilly and Company (US)
• Gilead Sciences, Inc. (US)
• Sanofi S.A (France)
• Nippon Shinyaku Co., Ltd. (Japan)
• United Therapeutics Corp. (US)
• Cipla Limited (India)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Treprostinil in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Treprostinil Market Report 2016

1 TREPROSTINIL OVERVIEW

1.1 Product Overview and Scope of Treprostinil
1.2 Classification of Treprostinil
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Treprostinil
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Treprostinil (2011-2021)
  1.4.1 United States Treprostinil Sales and Growth Rate (2011-2021)
  1.4.2 United States Treprostinil Revenue and Growth Rate (2011-2021)

2 UNITED STATES TREPROSTINIL COMPETITION BY MANUFACTURERS

2.1 United States Treprostinil Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Treprostinil Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Treprostinil Average Price by Manufactures (2015 and 2016)
2.4 Treprostinil Market Competitive Situation and Trends
  2.4.1 Treprostinil Market Concentration Rate
  2.4.2 Treprostinil Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES TREPROSTINIL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Treprostinil Sales and Market Share by Type (2011-2016)
3.2 United States Treprostinil Revenue and Market Share by Type (2011-2016)
3.3 United States Treprostinil Price by Type (2011-2016)
3.4 United States Treprostinil Sales Growth Rate by Type (2011-2016)

4 UNITED STATES TREPROSTINIL SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Treprostinil Sales and Market Share by Application (2011-2016)
4.2 United States Treprostinil Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES TREPROSTINIL MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Treprostinil Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals (Germany)
  5.2.2 Treprostinil Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer HealthCare Pharmaceuticals (Germany) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Treprostinil Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly and Company (US)
  5.4.2 Treprostinil Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly and Company (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Gilead Sciences, Inc. (US)
  5.5.2 Treprostinil Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Gilead Sciences, Inc. (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sanofi S.A (France)
  5.6.2 Treprostinil Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sanofi S.A (France) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Nippon Shinyaku Co., Ltd. (Japan)
  5.7.2 Treprostinil Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Nippon Shinyaku Co., Ltd. (Japan) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 United Therapeutics Corp. (US)
  5.8.2 Treprostinil Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 United Therapeutics Corp. (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Cipla Limited (India)
  5.9.2 Treprostinil Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Cipla Limited (India) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 TREPROSTINIL MANUFACTURING COST ANALYSIS

6.1 Treprostinil Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Treprostinil

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Treprostinil Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Treprostinil Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES TREPROSTINIL MARKET FORECAST (2016-2021)

10.1 United States Treprostinil Sales, Revenue Forecast (2016-2021)
10.2 United States Treprostinil Sales Forecast by Type (2016-2021)
10.3 United States Treprostinil Sales Forecast by Application (2016-2021)
10.4 Treprostinil Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Treprostinil
Table Classification of Treprostinil
Figure United States Sales Market Share of Treprostinil by Type in 2015
Table Application of Treprostinil
Figure United States Sales Market Share of Treprostinil by Application in 2015
Figure United States Treprostinil Sales and Growth Rate (2011-2021)
Figure United States Treprostinil Revenue and Growth Rate (2011-2021)
Table United States Treprostinil Sales of Key Manufacturers (2015 and 2016)
Table United States Treprostinil Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Treprostinil Sales Share by Manufacturers
Figure 2016 Treprostinil Sales Share by Manufacturers
Table United States Treprostinil Revenue by Manufacturers (2015 and 2016)
Table United States Treprostinil Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Treprostinil Revenue Share by Manufacturers
Table 2016 United States Treprostinil Revenue Share by Manufacturers
Table United States Market Treprostinil Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Treprostinil Average Price of Key Manufacturers in 2015
Figure Treprostinil Market Share of Top 3 Manufacturers
Figure Treprostinil Market Share of Top 5 Manufacturers
Table United States Treprostinil Sales by Type (2011-2016)
Table United States Treprostinil Sales Share by Type (2011-2016)
Figure United States Treprostinil Sales Market Share by Type in 2015
Table United States Treprostinil Revenue and Market Share by Type (2011-2016)
Table United States Treprostinil Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Treprostinil by Type (2011-2016)
Table United States Treprostinil Price by Type (2011-2016)
Figure United States Treprostinil Sales Growth Rate by Type (2011-2016)
Table United States Treprostinil Sales by Application (2011-2016)
Table United States Treprostinil Sales Market Share by Application (2011-2016)
Figure United States Treprostinil Sales Market Share by Application in 2015
Table United States Treprostinil Sales Growth Rate by Application (2011-2016)
Figure United States Treprostinil Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Treprostinil Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Treprostinil Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Treprostinil Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Treprostinil Sales Market Share (2011-2016)
Table Gilead Sciences, Inc. (US) Basic Information List
Table Gilead Sciences, Inc. (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences, Inc. (US) Treprostinil Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Treprostinil Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Treprostinil Sales Market Share (2011-2016)
Table United Therapeutics Corp. (US) Basic Information List
Table United Therapeutics Corp. (US) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corp. (US) Treprostinil Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Treprostinil Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Treprostinil Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Treprostinil
Figure Manufacturing Process Analysis of Treprostinil
Figure Treprostinil Industrial Chain Analysis
Table Raw Materials Sources of Treprostinil Major Manufacturers in 2015
Table Major Buyers of Treprostinil
Table Distributors/Traders List
Figure United States Treprostinil Production and Growth Rate Forecast (2016-2021)
Figure United States Treprostinil Revenue and Growth Rate Forecast (2016-2021)
Table United States Treprostinil Production Forecast by Type (2016-2021)
Table United States Treprostinil Consumption Forecast by Application (2016-2021)